Cefazolin Monotherapy Versus Cefazolin Plus Aminoglycosides for Antimicrobial Prophylaxis of Type III Open Fractures.

Patanwala, Asad E; Radosevich, John J; Meshay, Ian; Naderi, Mandana; Culver, Mark A; Lee, Yong G; Weinberg, Jordan A; Khobrani, Moteb; Nix, David E

Patanwala, Asad E; Radosevich, John J; Meshay, Ian; Naderi, Mandana; Culver, Mark A; Lee, Yong G; Weinberg, Jordan A; Khobrani, Moteb; Nix, David E.

Afiliação

Patanwala AE; School of Pharmacy, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia.
Radosevich JJ; Department of Pharmacy Services, St. Joseph's Hospital and Medical Center, Phoenix, AZ.
Meshay I; University of Arizona College of Medicine-Phoenix, Phoenix, AZ.
Naderi M; Department of Pharmacy Practice and Science, College of Pharmacy, The University of Arizona, Tucson, AZ.
Culver MA; Department of Pharmacy, Abrazo West Campus, Goodyear, AZ.
Lee YG; Department of Pharmacy Services, St. Joseph's Hospital and Medical Center, Phoenix, AZ.
Weinberg JA; Department of Surgery, St. Joseph's Hospital and Medical Center, Phoenix, AZ; and.
Khobrani M; College of Pharmacy, King Khalid University, Abha, Saudi Arabia.
Nix DE; Department of Pharmacy Practice and Science, College of Pharmacy, The University of Arizona, Tucson, AZ.

Am J Ther ; 28(3): e284-e291, 2019 Nov 25.

Article em En | MEDLINE | ID: mdl-31789627

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Observational_studies Idioma: En Revista: Am J Ther Assunto da revista: TERAPEUTICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google